Other studies indicated that miR-125b promotes CRC metastasis by targeting MCL1 [5] and enhances 5-FU resistance by activating the APC-mediated Wnt/β-catenin pathway [6]. This evidence concerns the gene MCL1 and colorectal carcinoma.